ALK-negative T-cell anaplastic large cell lymphoma associated with systemic lupus erythematosus

被引:0
|
作者
Nada Suvajdzic
Roksanda Stojanovic-Milenkovic
Zoran Tomasevic
Vesna Cemerikic-Martinovic
Biljana Mihaljevic
Henry D. E. Atkinson
机构
[1] Institute of Rheumatology,Imperial College Medical School
[2] Institute of Radiology and Oncology,Institute of Hematology
[3] Hammersmith Hospital,undefined
[4] Clinical Center of Serbia,undefined
来源
Medical Oncology | 2003年 / 20卷
关键词
T-cell anaplastic large cell lymphoma; systemic lupus erythematosus; pathogenesis; etiology;
D O I
暂无
中图分类号
学科分类号
摘要
Patients with systemic lupus erythematosus (SLE) appear to have an increased risk of developing malignancies, especially lymphomas. We report the development of a systemic ALK-negative T-cell anaplastic large cell lymphoma, stage IIB, in a 53-yr-old Caucasian female with a 12-yr history of stable SLE. The patient responded poorly to chemotherapy and died 2 yr after diagnosis. Lymphomas that develop in patients with SLE and other autoimmune diseases are virtually always of B-cell origin. To our knowledge this is the first report of a T-cell anaplastic large cell lymphoma in a patient with SLE. This article discusses the association of SLE and lymphoma, with an emphasis on T-lymphoproliferative states.
引用
收藏
页码:409 / 412
页数:3
相关论文
共 50 条
  • [31] Progress in the identification of subgroups in ALK-negative anaplastic large-cell lymphoma
    Boddicker, Rebecca L.
    Feldman, Andrew L.
    BIOMARKERS IN MEDICINE, 2015, 9 (08) : 719 - 722
  • [32] Leukemic presentation of a highly aggressive ALK-negative anaplastic large cell lymphoma
    Xu, Danmei
    Naresh, Kikkeri N.
    BLOOD, 2021, 138 (13) : 1198 - 1198
  • [33] Systemic ALK-negative anaplastic large cell lymphoma: Insights into morphologic, immunophenotypic, genetic and molecular characteristics
    Xie, Wei
    Medeiros, L. Jeffrey
    Fan, Guang
    Li, Shaoying
    Xu, Jie
    HUMAN PATHOLOGY, 2025, 156
  • [34] ALK-negative primary cutaneous T-cell anaplastic large cell lymphoma, myxoid variant; masquerading as sarcoma: unveiling the diagnostic dilemma
    Misra, Medha
    Raghuvanshi, Shivanjali
    Goel, Madhu Mati
    Verma, Shailendra Prasad
    BMJ CASE REPORTS, 2021, 14 (02)
  • [35] BREAST IMPLANT ASSOCIATED ALK NEGATIVE ANAPLASTIC LARGE T CELL LYMPHOMA
    Neppalli, A. K.
    Koshy, N., V
    JOURNAL OF INVESTIGATIVE MEDICINE, 2013, 61 (02) : 407 - 407
  • [36] Outcomes of ALK-negative Anaplastic Large Cell Lymphoma are Superior to Peripheral T-cell Lymphoma, Not Otherwise Specified: Report From a Single Chinese Institution
    Zhang, X.
    Li, Y.
    Wang, S.
    Wang, W.
    Jin, J.
    Liu, Y.
    Song, Y.
    Liu, X.
    Zhou, L.
    Yu, Z.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S617 - S617
  • [37] DUSP22 rearrangement is associated with a distinctive immunophenotype but not outcome in patients with systemic ALK-negative anaplastic large cell lymphoma
    Qiu, Lianqun
    Tang, Guilin
    Li, Shaoying
    Vega, Francisco
    Lin, Pei
    Wang, Sa A.
    Wang, Wei
    Iyer, Swaminathan P.
    Malpica, Luis
    Miranda, Roberto N.
    Konoplev, Sergej
    Tang, Zhenya
    Fang, Hong
    Medeiros, L. Jeffrey
    Xu, Jie
    HAEMATOLOGICA, 2023, 108 (06) : 1604 - 1615
  • [38] Primary Central Nervous System ALK-Negative Anaplastic T-Cell Lymphoma is a Challenging and Uncommon Diagnosis
    Mohamed, R.
    Howell, D.
    Cheng, H. Peng
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2023, 160 : S74 - S75
  • [39] Molecular genetic data favoring a sequential clonal transformation of a large B cell lymphoma into an anaplastic large T cell lymphoma, ALK-negative
    Tomas Vanecek
    Kimberly Walker
    Linden L Watson
    Arundhati Rao
    Debby Rampisela
    Ludvik R. Donner
    Journal of Hematopathology, 2015, 8 : 243 - 253
  • [40] Primary Central Nervous System ALK-Negative Anaplastic T-Cell Lymphoma is a Challenging and Uncommon Diagnosis
    Mohamed, R.
    Howell, D.
    Cheng, H. Peng
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2023, 160 : S74 - S75